Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Omar Al-Louzi, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Caldito NG, Saidha S, Sotirchos ES, Dewey BE, Cowley NJ, Glaister J, Fitzgerald KC, Al-Louzi O, Nguyen J, Rothman A, Ogbuokiri E, Fioravante N, Feldman S, Kwakyi O, Risher H, Kimbrough D, Frohman TC, Frohman E, Balcer L, Crainiceanu C, Van Zijl PCM, Mowry EM, Reich DS, Oh J, Pham DL, Prince J, Calabresi PA. Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study. Brain. 2018 Nov 01; 141(11):3115-3129. PMID: 30312381.
    View in: PubMed
  2. Al-Louzi O, Prasad S, Mallery RM. Utility of optical coherence tomography in the evaluation of sellar and parasellar mass lesions. Curr Opin Endocrinol Diabetes Obes. 2018 Aug; 25(4):274-284. PMID: 29771751.
    View in: PubMed
  3. Al-Louzi O, Sotirchos ES, Vidal-Jordana A, Beh SC, Button J, Ying HS, Balcer LJ, Frohman EM, Saidha S, Calabresi PA, Newsome SD. Characteristics of morphologic macular abnormalities in neuroimmunology practice. Mult Scler. 2017 Nov 01; 1352458517741206. PMID: 29125422.
    View in: PubMed
  4. Al-Louzi O, Button J, Newsome SD, Calabresi PA, Saidha S. Retrograde trans-synaptic visual pathway degeneration in multiple sclerosis: A case series. Mult Scler. 2017 Jun; 23(7):1035-1039. PMID: 28385128.
    View in: PubMed
  5. Button J, Al-Louzi O, Lang A, Bhargava P, Newsome SD, Frohman T, Balcer LJ, Frohman EM, Prince J, Calabresi PA, Saidha S. Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study. Neurology. 2017 02 07; 88(6):525-532. PMID: 28077493.
    View in: PubMed
  6. Antony BJ, Lang A, Swingle EK, Al-Louzi O, Carass A, Solomon S, Calabresi PA, Saidha S, Prince JL. Simultaneous Segmentation of Retinal Surfaces and Microcystic Macular Edema in SDOCT Volumes. Proc SPIE Int Soc Opt Eng. 2016 Feb 27; 9784. PMID: 27199502.
    View in: PubMed
  7. Antony BJ, Chen M, Carass A, Jedynak BM, Al-Louzi O, Solomon SD, Saidha S, Calabresi PA, Prince JL. Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings. Proc SPIE Int Soc Opt Eng. 2016 Feb 27; 9788. PMID: 27199503.
    View in: PubMed
  8. Lang A, Carass A, Al-Louzi O, Bhargava P, Solomon SD, Calabresi PA, Prince JL. Combined registration and motion correction of longitudinal retinal OCT data. Proc SPIE Int Soc Opt Eng. 2016 Feb 27; 9784. PMID: 27231406.
    View in: PubMed
  9. Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome SD, Prince JL, Pham D, Roy S, van Zijl P, Balcer LJ, Frohman EM, Reich DS, Crainiceanu C, Calabresi PA. Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study. Ann Neurol. 2015 Nov; 78(5):801-13. PMID: 26190464; PMCID: PMC4703093.
  10. Saidha S, Al-Louzi O. Author response. Neurology. 2015 Aug 25; 85(8):743. PMID: 26528523.
    View in: PubMed
  11. Al-Louzi OA, Bhargava P, Newsome SD, Balcer LJ, Frohman EM, Crainiceanu C, Calabresi PA, Saidha S. Outer retinal changes following acute optic neuritis. Mult Scler. 2016 Mar; 22(3):362-72. PMID: 26209589; PMCID: PMC4724567 [Available on 03/01/17].
  12. Bhargava P, Lang A, Al-Louzi O, Carass A, Prince J, Calabresi PA, Saidha S. Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials. Mult Scler Int. 2015; 2015:136295. PMID: 26090228; PMCID: PMC4452193.
  13. Kimbrough DJ, Sotirchos ES, Wilson JA, Al-Louzi O, Conger A, Conger D, Frohman TC, Saidha S, Green AJ, Frohman EM, Balcer LJ, Calabresi PA. Retinal damage and vision loss in African American multiple sclerosis patients. Ann Neurol. 2015 Feb; 77(2):228-36. PMID: 25382184; PMCID: PMC4315746.
  14. Lang A, Carass A, Al-Louzi O, Bhargava P, Ying HS, Calabresi PA, Prince JL. Longitudinal graph-based segmentation of macular OCT using fundus alignment. Proc SPIE Int Soc Opt Eng. 2015; 9413. PMID: 26023248.
    View in: PubMed
  15. Swingle EK, Lang A, Carass A, Al-Louzi O, Saidha S, Prince JL, Calabresi PA. Segmentation of microcystic macular edema in Cirrus OCT scans with an exploratory longitudinal study. Proc SPIE Int Soc Opt Eng. 2015; 9417. PMID: 26023249.
    View in: PubMed
  16. Lang A, Carass A, Swingle EK, Al-Louzi O, Bhargava P, Saidha S, Ying HS, Calabresi PA, Prince JL. Automatic segmentation of microcystic macular edema in OCT. Biomed Opt Express. 2015 Jan 01; 6(1):155-69. PMID: 25657884; PMCID: PMC4317118.
  17. Al-Louzi O, Hauptman H, Saidha S. Biopsy-negative PET-positive giant-cell arteritis. Neurology. 2014 Oct 28; 83(18):1674-6. PMID: 25274846.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Al-Louzi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (41)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.